Rilmazafone
Rilmazafone structure
|
Common Name | Rilmazafone | ||
|---|---|---|---|---|
| CAS Number | 99593-25-6 | Molecular Weight | 475.33 | |
| Density | 1.45g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C21H20Cl2N6O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RilmazafoneRilmazafone is a benzodiazepine (omega) ligand with sedative and hypnotic effects[1]. |
| Name | 5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide |
|---|---|
| Synonym | More Synonyms |
| Description | Rilmazafone is a benzodiazepine (omega) ligand with sedative and hypnotic effects[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.45g/cm3 |
|---|---|
| Molecular Formula | C21H20Cl2N6O3 |
| Molecular Weight | 475.33 |
| Exact Mass | 474.09700 |
| PSA | 123.21000 |
| LogP | 3.17300 |
| Index of Refraction | 1.671 |
|
~%
Rilmazafone CAS#:99593-25-6 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 19, # 6 p. 1363 - 1369 |
|
~%
Rilmazafone CAS#:99593-25-6 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 19, # 6 p. 1363 - 1369 |
|
~%
Rilmazafone CAS#:99593-25-6 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 19, # 6 p. 1363 - 1369 |
|
~%
Rilmazafone CAS#:99593-25-6 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 19, # 6 p. 1363 - 1369 |
|
~%
Rilmazafone CAS#:99593-25-6 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 19, # 6 p. 1363 - 1369 |
| 1-[4-chloro-2-(2-chloro-benzoyl)-phenyl]-5-(glycylamino-methyl)-1H-[1,2,4]triazole-3-carboxylic acid dimethylamide |
| rilmazafone |
| 1-[4-bromo-3-methylphenyl]-1H-pyrrole-2,5-dione |
| 2',5-dichloro-2-(3-dimethylcarbamoyl-5-glycylaminomethyl-1H-1,2,4-triazol-1-yl)benzophenone |